Yale Rheumatology State of the Art Symposium: Pre-autoimmunity and the Prevention of Rheumatic Diseases
Recent progress in our understanding of the development of autoimmunity suggests the opportunity of intervening in the prodromal phase of rheumatic diseases to prevent the future onset of clinically-apparent disease, such as arthritis or other disease manifestations.
This one-day international symposium will bring thought leaders together to review the conceptual basis and available clinical data for implementing preventive strategies in rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune and rheumatic conditions. Topics will include the definition of at-risk individuals, interventions under study, and prospects for new approaches in basic scientific and clinical investigation, and for the design of therapeutic clinical trials.
Date: Wednesday, May 19, 2021
Time: 8 a.m - 4 p.m.
Live Zoom webinar
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Richard Bucala, MD, PhD, Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and Professor of Pathology and of Epidemiology (Microbial Diseases); Chief, Rheumatology, Allergy, & Immunology; Rheumatologist in Chief, Rheumatology
Ned Calonge, MD, President and CEO, the Colorado Trust
Ben Chong, MD, Assistant Instructor, University of Texas Southwestern Medical Center
Andrew Cope, MD, PhD, Professor of Rheumatology, King's College London
Philip De Jager, MD, PhD, Professor of Neurology, CUMC/Neurological Institute of New York
Kevin Deane, MD, PhD, Associate Professor of Medicine, Division of Rheumatology, University of Colorado Hospital, Veterans Affairs Medical Center
Hani El-Gabalawy, MD, FRCPC, Professor of Medicine and Immunology, University of Manitoba Arthritis Center
Peter C. Grayson, MD, MSc, Tenure Track Investigator, NIAMS Vasculitis Translational Research Program, National Institutes of Health
Mark Harrison, PhD, Associate Professor, Faculty of Pharmaceutical Sciences, University of British Columbia
Andrew Heinrich, JD, MPhil, Lecturer, Yale School of Public Health
Kevan Herold, MD, C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)
Judith James, MD, PhD, Vice President of Clinical Affairs, Oklahoma Medical Research Foundation
David Karp, MD, PhD, Professor and Chief, Rheumatic Disease Division, University of Texas Southwestern Medical Center
Nancy Olsen, MD, Department of Rheumatology, Penn State M.S. Hershey Medical Center
Christopher T. Ritchlin, MD, MPH, Professor of Medicine and Chief - Department of Medicine, Allergy/Immunology and Rheumatology (SMD), University of Rochester Medical Center
Event RSVP: Allison Rentfro, PhD
REGISTRATION FEES: Physicians - $50 Nurses/PAs/Allied Health Professionals - $25 Residents/Fellows/Students† - Complimentary Exhibits - $1500
Host Organization: Rheumatology, Allergy, & Immunology